Oligoamine compounds and derivatives thereof for cancer therapy
Details for Australian Patent Application No. 2002340224 (hide)
International Classifications
Event Publications
27 February 2003 Complete Application Filed
Priority application(s): 60/329,982 16.10.01 US
3 July 2003 Application Open to Public Inspection
Published as AU-B-2002340224
11 August 2005 Assignment before Grant
SLIL Biomedical Corporation The application has been assigned to CellGate, Inc.
27 November 2008 Application Accepted
Published as AU-B-2002340224
11 December 2008 Alteration of Name
The name of the applicant has been altered to Progen Pharmaceuticals, Inc
26 March 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser